Academic Training in Rheumatology

描述（由申请人提供）：医学的最大挑战是将当代科学的最新发展带到床边。这一挑战只能通过培养一支能够进行高质量研究的研究人员队伍来应对，以加强以患者为导向的研究。因此，这项培训补助金提案寻求支持，以准备个人（MD，MD/PhD或PhD）在生物医学科学的职业生涯，因为它涉及到流变学。该计划是基于流变学的一个大部门，有30名教职员工，包括14名联邦资助的研究人员和积极的临床和基础研究计划。流变学分部，包括其相关诊所，是加州大学洛杉矶分校大卫格芬医学院及其临床和生物医学科学系的一部分。主要的教师顾问不仅来自医学系内的部门，而且来自病理学，微生物学/免疫学/分子学的部门。遗传学、药理学和公共卫生学院。涵盖的广泛专业领域包括自身免疫，基础免疫学，临床干预和治疗，基因组学，基因表达和治疗，健康质量，经济学和政策。该计划得到了核心设施以及学术课程和PI发起的校园范围内的翻译免疫学计划的大力支持。据信，这个流变学计划提供了独特的资源，并将继续扩大个人的研究，因为它涉及到亚专业的职业兴趣，这是一个池太小，以满足未来几十年的要求，分子医学越来越多地应用于临床。 奖学金计划的第一年包括广泛的临床培训，并通过当地来源资助。在第二年和第三年，学员将在他/她选择的研究领域工作，同时保持足够的临床活动，以满足专业委员会的要求。希望和/或需要经验的学员过渡到学术研究者将通过拟议的T32资助，并为那些谁选择博士或硕士课程，通过加州大学洛杉矶分校星星（高级研究专业培训）计划。该申请寻求对关键的2年期间的支持，该期间将学员从她/他的最初临床风湿病学经验过渡到学术风湿病学的职业生涯。该申请还寻求为期两年的培训支持，为非临床博士后学员谁希望在流变学培训，以发展在该子专业的学术研究生涯。

DESCRIPTION (provided by applicant): The greatest challenge to medicine is to bring to the bedside the latest developments in contemporary science. This challenge can only be met by developing a cadre of investigators who can conduct high quality research that is geared to strengthen patient-oriented investigations. Hence, this training grant proposal seeks support to prepare individuals (MD, MD/PhD, or PhD) for a career in biomedical science as it relates to Rheumatology. The program is based in a large Division of Rheumatology with 30 faculty members including 14 federally funded investigators and active clinical and basic research programs. The Division of Rheumatology, including its related clinics, is part of the David Geffen School of Medicine at UCLA with its clinical and biomedical science departments. The primary faculty advisors come not only from divisions within the Department of Medicine but also from the Departments of Pathology, Microbiol/lmmunol /Mol. Genetics, Pharmacology, and School of Public Health. The broad areas of expertise covered include autoimmunity, basic immunology, clinical intervention and therapeutics, genomics, gene expression and therapy, and health quality, economics and policy. The program is well supported by core facilities as well as by academic courses and a campus-wide translational immunology program initiated by the PI. It is believed that this Rheumatology program provides unique resources and will continue to enlarge the pool of individuals with a career interest in research as it relates to the subspecialty, a pool that is far too small to meet the requirements of the next decades as molecular medicine is increasingly applied in the clinic. The first year of the fellowship program consists of extensive clinical training and is funded through local sources. During the 2nd and 3rd years, the trainee will work in his/her chosen area of research, while maintaining sufficient clinical activity to fulfill the specialty board requirements. The trainees desiring and/or requiring experience to make the transition to academic investigator will be funded through the proposed T32 and for those who elect PhD or Master's curricula, through the UCLA STAR (Specialty Training in Advanced Research) program. This application seeks support for the critical 2-year period which transitions the trainee from her/his initial clinical rheumatology experience to a career in academic rheumatology. The application also seeks two-year training support for non-clinical postdoctoral trainees who desire to train in Rheumatology to develop an academic research career in the subspecialty.